相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
Personalized air quality monitoring and respiratory health in moderate and severe asthma: Findings from a six-month observational study.
Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomes.
Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project.
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
When Pneumonia is not Pneumonia: Pulmonary Venous Thrombosis After Scimitar Syndrome Repair.
Building the Future of Interventional Pulmonology: Reflections from the Forum of La Gomera.
[Sepsis in the Intermediate Respiratory Care Unit: Restrospective Study].
Pulmonary Mass as a Rare Pulmonary Manifestation of Inflammatory Bowel Disease.
[BioSAT: Development and conceptual validation of a satisfaction questionnaire regarding biologic therapies for severe asthma through a structured patient-professional co-creation process].
Nintedanib in a Dialysis Patient with Idiopathic Pulmonary Fibrosis: A One-Year Follow-Up Without Major Adverse Events.
[慢性阻塞性肺部疾病]
Elena García Castillo1, Gianna Vargas2, José Alfonso García Guerra3
1Servicio de Neumología, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria La Princesa, Universidad Autónoma de Madrid (UAM), Madrid, España. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España.
慢性阻塞性肺病 (COPD) 管理涉及基于表型和可治疗特征的个性化治疗. 早期查和了解恶化的生物标志物对于改善患者的治疗结果和生活质量至关重要.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 肺部病理学 肺部病理学
- 临床科学 临床科学


